| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |